Objective To evaluate the outcomes of tracheobronchial stenting in patients with malignant central airway obstruction and assist practitioners in palliative settings in understanding the indications, contraindications and management of tracheobronchial stents.
Methods This retrospective study involved a consecutive case series of palliative patients with central airway obstruction secondary to inoperable cancers who underwent tracheobronchial stenting at a single institution. The European Cooperative Oncology Group (ECOG) scale was used to evaluate patient functional status before and after tracheobronchial stenting.
Results Twenty-three patients underwent tracheobronchial stenting for malignant central airway obstruction. The majority of patients presented with symptoms of worsening dyspnoea (21 of 23; 91%). Postoperatively, there was a significant improvement in mean ECOG performance status from 2.88±0.34 to 1.58±0.50 (p<0.01). There was no intraoperative mortality resulting from tracheobronchial stenting. Five patients (21.74%) re-presented to hospital due to worsening symptoms and required emergency bronchoscopy. Two patients had stent migration, requiring stent replacement. One patient restenosed from tumour granulation, requiring microdebrider to debulk the mass. Two patients had stent failure secondary to external tumour compression, leading to death.
Conclusion Tracheobronchial stenting is a safe and effective procedure that offers rapid palliation of symptoms and improvement in patient functional status.
- head and neck
- quality of life
- supportive care
- tracheobronchial stent
Statistics from Altmetric.com
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Contributors RT and RYC contributed to the conception and design. RT, RYC and PF contributed to the interpretation and manuscript writing. RYC was responsible for the final approval of the article.
Funding This study was funded by the Department of Otolaryngology, Nepean Hospital, Sydney, Australia for the purposes of ethics application and data collection.
Competing interests None declared.
Patient consent Not required.
Ethics approval Nepean Blue Mountains Local Health District Human Research Ethics Committee (LNR/18/NEPEAN/16) .
Provenance and peer review Not commissioned; externally peer reviewed.